Literature DB >> 2502844

Cloning and sequencing of porcine LH-hCG receptor cDNA: variants lacking transmembrane domain.

H Loosfelt1, M Misrahi, M Atger, R Salesse, M T Vu Hai-Luu Thi, A Jolivet, A Guiochon-Mantel, S Sar, B Jallal, J Garnier.   

Abstract

Complementary DNA clones, encoding the LH-hCG (luteinizing hormone-human choriogonadotropic hormone) receptor were isolated by screening a lambda gt11 library with monoclonal antibodies. The primary structure of the protein was deduced from the DNA sequence analysis; the protein contains 696 amino acids with a putative signal peptide of 27 amino acids. Hydropathy analysis suggests the existence of seven transmembrane domains that show homology with the corresponding regions of other G protein-coupled receptors. Three other types of clones corresponding to shorter proteins were observed, in which the putative transmembrane domain was absent. These probably arose through alternative splicing. RNA blot analysis showed similar patterns in testis and ovary with a major RNA of 4700 nucleotides and several minor species. The messenger RNA was expressed in COS-7 cells, yielding a protein that bound hCG with the same affinity as the testicular receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502844     DOI: 10.1126/science.2502844

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  63 in total

1.  Expression of endothelial nitric oxide synthase in the porcine oocyte and its possible function.

Authors:  M A Hattori; K Takesue; Y Kato; N Fujihara
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Synthetic peptides based upon a three-dimensional model for the receptor recognition site of follicle-stimulating hormone exhibit antagonistic or agonistic activity at low concentrations.

Authors:  M Hage-van Noort; W C Puijk; H H Plasman; D Kuperus; W M Schaaper; N J Beekman; J A Grootegoed; R H Meloen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

3.  RTA, a candidate G protein-coupled receptor: cloning, sequencing, and tissue distribution.

Authors:  P C Ross; R A Figler; M H Corjay; C M Barber; N Adam; D R Harcus; K R Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Effect of chronic thyroid hormone treatment on cycling, ovulation, serum reproductive hormones and ovarian LH and prolactin receptors in rats.

Authors:  G A Jahn; G Moya; H Jammes; R R Rosato
Journal:  Endocrine       Date:  1995-02       Impact factor: 3.633

5.  Functional study of an aberrant splicing variant of the human luteinizing hormone (LH) receptor.

Authors:  Bing Han; Zhi-quan Wang; Li-qiong Xue; Jun-hua Ma; Wei Liu; Bing-li Liu; Jia-jun Wu; Chun-ming Pan; Xia Chen; Shuang-xia Zhao; Ying-li Lu; Wan-ling Wu; Jie Qiao; Huai-dong Song
Journal:  Mol Hum Reprod       Date:  2011-10-14       Impact factor: 4.025

Review 6.  Molecular pharmacology of gonadotropins.

Authors:  Robert K Campbell
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

Review 7.  Models of glycoprotein hormone receptor interaction.

Authors:  William R Moyle; Win Lin; Rebecca V Myers; Donghui Cao; John E Kerrigan; Michael P Bernard
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

Review 8.  Gonadotropin receptors: role of post-translational modifications and post-transcriptional regulation.

Authors:  K M J Menon; Christine L Clouser; Anil K Nair
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

9.  Native avian c-erbB gene expresses a secreted protein product corresponding to the ligand-binding domain of the receptor.

Authors:  N J Maihle; T W Flickinger; M A Raines; M L Sanders; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

Review 10.  Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.

Authors:  M L Halls; E T van der Westhuizen; R A D Bathgate; R J Summers
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.